IP protection

1

Please provide a short description of the state-of-the-art and/or current trends in the field? How does the result fit into it?
The extended-release formulation treatment is an essential element of certain diseases. Formulating biologically active proteins (e.g. enzymes, hormones, and cytokines) as drugs poses a number of specific problems related to the preservation of biological activity through the conservation of higher order protein structures.

 

 

 

 

2

What is the problem/need/knowledge gap that the research result is responding to?  How was it addressed before?
The invention is a novel method of core-shell nanoparticle preparation of protein drugs or protein-bound active compounds, which provides a way of the formulation of sustained release products. The result of using it is a designed drug-delivery, and an extended life quality for patients.

 

3

What is the potential for further research?
 

 

 

 

 

 

4

What is the proposed method of IPR-protection? (patent, license, trademark etc.)
The patent family is based on patent application publication number WO2008HU00028 20080307. The European national phase is currently in progress.

 

 

 

 

5

What are the steps that need to be taken in order to secure the IPR-protection? What is the cost of IPR-protection?
 

 

 

 

 

 

6

What is you overall assessment of the scientific maturity of the research result?
The invention is a novel method of core-shell nanoparticle preparation of protein drugs or protein-bound active compounds, which provides a way of the formulation of sustained release products.

 

 

 

KEYWORDS QUANTITATIVE ASSESSMENT (0-5).

Please put X as appropriate. 1 2 3 4 5
Scientific maturity         X
Synergies         X
State-of-the-art/innovation         X
IPR-potential         X

 

Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Related Documents

There in no related documents

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project